Cargando…
Safety and efficacy of complementary and alternative medicine in the treatment of autism spectrum disorder: A protocol for systematic review and meta-analysis
INTRODUCTION: The purpose of this study is to evaluate the efficacy and safety of complementary and alternative medicine in the treatment of autism spectrum disorder. METHODS AND ANALYSIS: We will electronically search Pubmed, Medline, Embase, Web of Science, the Cochrane Central Register of Control...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647561/ https://www.ncbi.nlm.nih.gov/pubmed/33157993 http://dx.doi.org/10.1097/MD.0000000000023128 |
_version_ | 1783606935424073728 |
---|---|
author | Shuai, Biqin Jin, Hongjiao Lin, Yong Duan, Renrong Zhao, Ning Li, Zhu Mao, Jiao Luo, Yan Shi, Mengyu |
author_facet | Shuai, Biqin Jin, Hongjiao Lin, Yong Duan, Renrong Zhao, Ning Li, Zhu Mao, Jiao Luo, Yan Shi, Mengyu |
author_sort | Shuai, Biqin |
collection | PubMed |
description | INTRODUCTION: The purpose of this study is to evaluate the efficacy and safety of complementary and alternative medicine in the treatment of autism spectrum disorder. METHODS AND ANALYSIS: We will electronically search Pubmed, Medline, Embase, Web of Science, the Cochrane Central Register of Controlled Trial, China National Knowledge Infrastructure, China Biomedical Literature Database, China Science Journal Database, and Wan-fang Database from their inception. Also, we will manually retrieve other resources, including reference lists of identified publications, conference articles, and gray literature. The clinical randomized controlled trials or quasi-randomized controlled trials related to complementary and alternative medicine treating autism spectrum disorder will be included in the study. The language is limited to Chinese and English. Research selection, data extraction, and research quality assessment will be independently completed by 2 researchers. Data were synthesized by using a fixed-effect model or random-effect model depend on the heterogeneity test. The Childhood Autism Rating Scale (CARS) and Autism Behavior Checklist (ABC) scores will be the primary outcomes. The scores of the Autism Treatment Evaluation Checklist and the Ritvo-Freeman Real Life Rating Scale will also be assessed as secondary outcomes. RevMan V.5.3 statistical software will be used for meta-analysis, and the level of evidence will be assessed by Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Continuous data will be expressed in the form of weighted mean difference or standardized mean difference with 95% confidence intervals (CIs), whereas dichotomous data will be expressed in the form of relative risk with 95% CIs. ETHICS AND DISSEMINATION: The protocol of this systematic review does not require ethical approval because it does not involve humans. We will publish this article in peer-reviewed journals and presented at relevant conferences. SYSTEMATIC REVIEW REGISTRATION: OSF Registries, DOI: 10.17605/OSF.IO/ HA97R (https://osf.io/ha97r) |
format | Online Article Text |
id | pubmed-7647561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-76475612020-11-09 Safety and efficacy of complementary and alternative medicine in the treatment of autism spectrum disorder: A protocol for systematic review and meta-analysis Shuai, Biqin Jin, Hongjiao Lin, Yong Duan, Renrong Zhao, Ning Li, Zhu Mao, Jiao Luo, Yan Shi, Mengyu Medicine (Baltimore) 3800 INTRODUCTION: The purpose of this study is to evaluate the efficacy and safety of complementary and alternative medicine in the treatment of autism spectrum disorder. METHODS AND ANALYSIS: We will electronically search Pubmed, Medline, Embase, Web of Science, the Cochrane Central Register of Controlled Trial, China National Knowledge Infrastructure, China Biomedical Literature Database, China Science Journal Database, and Wan-fang Database from their inception. Also, we will manually retrieve other resources, including reference lists of identified publications, conference articles, and gray literature. The clinical randomized controlled trials or quasi-randomized controlled trials related to complementary and alternative medicine treating autism spectrum disorder will be included in the study. The language is limited to Chinese and English. Research selection, data extraction, and research quality assessment will be independently completed by 2 researchers. Data were synthesized by using a fixed-effect model or random-effect model depend on the heterogeneity test. The Childhood Autism Rating Scale (CARS) and Autism Behavior Checklist (ABC) scores will be the primary outcomes. The scores of the Autism Treatment Evaluation Checklist and the Ritvo-Freeman Real Life Rating Scale will also be assessed as secondary outcomes. RevMan V.5.3 statistical software will be used for meta-analysis, and the level of evidence will be assessed by Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Continuous data will be expressed in the form of weighted mean difference or standardized mean difference with 95% confidence intervals (CIs), whereas dichotomous data will be expressed in the form of relative risk with 95% CIs. ETHICS AND DISSEMINATION: The protocol of this systematic review does not require ethical approval because it does not involve humans. We will publish this article in peer-reviewed journals and presented at relevant conferences. SYSTEMATIC REVIEW REGISTRATION: OSF Registries, DOI: 10.17605/OSF.IO/ HA97R (https://osf.io/ha97r) Lippincott Williams & Wilkins 2020-11-06 /pmc/articles/PMC7647561/ /pubmed/33157993 http://dx.doi.org/10.1097/MD.0000000000023128 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 3800 Shuai, Biqin Jin, Hongjiao Lin, Yong Duan, Renrong Zhao, Ning Li, Zhu Mao, Jiao Luo, Yan Shi, Mengyu Safety and efficacy of complementary and alternative medicine in the treatment of autism spectrum disorder: A protocol for systematic review and meta-analysis |
title | Safety and efficacy of complementary and alternative medicine in the treatment of autism spectrum disorder: A protocol for systematic review and meta-analysis |
title_full | Safety and efficacy of complementary and alternative medicine in the treatment of autism spectrum disorder: A protocol for systematic review and meta-analysis |
title_fullStr | Safety and efficacy of complementary and alternative medicine in the treatment of autism spectrum disorder: A protocol for systematic review and meta-analysis |
title_full_unstemmed | Safety and efficacy of complementary and alternative medicine in the treatment of autism spectrum disorder: A protocol for systematic review and meta-analysis |
title_short | Safety and efficacy of complementary and alternative medicine in the treatment of autism spectrum disorder: A protocol for systematic review and meta-analysis |
title_sort | safety and efficacy of complementary and alternative medicine in the treatment of autism spectrum disorder: a protocol for systematic review and meta-analysis |
topic | 3800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647561/ https://www.ncbi.nlm.nih.gov/pubmed/33157993 http://dx.doi.org/10.1097/MD.0000000000023128 |
work_keys_str_mv | AT shuaibiqin safetyandefficacyofcomplementaryandalternativemedicineinthetreatmentofautismspectrumdisorderaprotocolforsystematicreviewandmetaanalysis AT jinhongjiao safetyandefficacyofcomplementaryandalternativemedicineinthetreatmentofautismspectrumdisorderaprotocolforsystematicreviewandmetaanalysis AT linyong safetyandefficacyofcomplementaryandalternativemedicineinthetreatmentofautismspectrumdisorderaprotocolforsystematicreviewandmetaanalysis AT duanrenrong safetyandefficacyofcomplementaryandalternativemedicineinthetreatmentofautismspectrumdisorderaprotocolforsystematicreviewandmetaanalysis AT zhaoning safetyandefficacyofcomplementaryandalternativemedicineinthetreatmentofautismspectrumdisorderaprotocolforsystematicreviewandmetaanalysis AT lizhu safetyandefficacyofcomplementaryandalternativemedicineinthetreatmentofautismspectrumdisorderaprotocolforsystematicreviewandmetaanalysis AT maojiao safetyandefficacyofcomplementaryandalternativemedicineinthetreatmentofautismspectrumdisorderaprotocolforsystematicreviewandmetaanalysis AT luoyan safetyandefficacyofcomplementaryandalternativemedicineinthetreatmentofautismspectrumdisorderaprotocolforsystematicreviewandmetaanalysis AT shimengyu safetyandefficacyofcomplementaryandalternativemedicineinthetreatmentofautismspectrumdisorderaprotocolforsystematicreviewandmetaanalysis |